Middle East & Africa Diabetes Care Devices Market To Reach $1.79 Billion By 2030

Middle East & Africa Diabetes Care Devices Market Growth & Trends

The Middle East & Africa diabetes care devices market size is anticipated to reach USD 1.79 billion by 2030, growing at a CAGR of 8.20% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rapidly growing technological innovations and an increase in obesity prevalence primarily fuel the demand for diabetes care devices in the MEA. Furthermore, the increasing prevalence of diabetes, strategic initiatives such as collaborations and partnerships, and the rising use of insulin-delivery devices are boosting the market in the MEA. For instance, in December 2023, the International Diabetes Federation (IDF) and FIND joined to strengthen the expertise in continuous glucose monitoring (CGM) technology for healthcare professionals and diabetes patients. This partnership, known as ACCEDE (Improving CGM Access for Diabetes Equality), targets improving diabetes care through CGM usage in underprivileged nations, mainly focusing on Kenya and South Africa, which are low-income countries.

The growing awareness of diabetes care is driving the Middle East and Africa industry. With the rising prevalence of chronic diseases, the adoption of healthier lifestyles, and growing government initiatives, raises the demand, resulting in market expansion. For instance, in 2021, the UAE government has set a goal to improve its citizens' overall health and well-being, including reducing the prevalence of chronic diseases like diabetes. The National Agenda for UAE Vision 2021 includes strategies to enhance healthcare services, promote healthy lifestyles, and invest in research and innovation in the healthcare sector. These initiatives aim to reduce the burden of diabetes on the healthcare system and improve patients' overall quality of life.

 Request a free sample copy or view report summary: Middle East & Africa Diabetes Care Devices Market Report

Middle East & Africa Diabetes Care Devices Market Report Highlights

• Based on type, the insulin delivery devices segment held the largest market share of 54.2% in 2023 and is expected to witness the fastest CAGR from 2024 to 2030. These devices are primarily used by individuals with diabetes who require insulin therapy to regulate their blood sugar. Insulin pens, pumps, needles, and syringes are the most widely used insulin delivery devices.

• Based on the distribution channel, the hospital pharmacies segment accounted for the largest revenue share in 2023. Hospital pharmacies stock various diabetes care devices, including blood glucose monitors, insulin delivery systems, and continuous glucose monitoring (CGM) systems.

• In terms of end-use, the hospital segment held the largest market revenue share in 2023. The hospital segment is expected to continue dominating the market due to the high foot traffic and availability of products, making it easier for patients to obtain diabetes care devices.

• This growth can be attributed to various market drivers, including technological advancements, increasing healthcare expenditure, and growing awareness about diabetes management.

• In October 2022, Nemaura Medical, Inc. received a tentative purchase order from TPMENA, their licensed company for the MENA region, for the sugarBEAT system. Nemaura Medical, Inc. is a medical technology firm dedicated to creating and marketing non-invasive wearable diagnostic devices, including CGM devices, and offering customized lifestyle coaching programs. The sugarBEAT system is an AI-powered CGM device.

Middle East & Africa Diabetes Care Devices Market Segmentation

Grand View Research has segmented the Middle East & Africa diabetes care devices market based on the type, distribution channel, end-use, and country:

MEA Diabetes Care Devices Type Outlook (Revenue, USD Million, 2018 - 2030)

• BGM Devices

  • Self-Monitoring Devices

    • Blood Glucose Meters

    • Testing Strips

    • Lancets

  • Continuous Glucose Monitoring Devices

    • Sensors

    • Transmitters

    • Receiver

• Insulin Delivery Devices

  • Pumps

  • Pens

  • Syringes

  • Jet Injectors

MEA Diabetes Care Devices Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies

• Retail Pharmacies

• Diabetes Clinics/Centers

• Online Pharmacies

• Others

MEA Diabetes Care Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Diagnostic Centers

• Homecare

MEA Diabetes Care Devices Country Outlook (Revenue, USD Million, 2018 - 2030)

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Middle East & Africa Diabetes Care Devices Market

• Abbott

• Dexcom, Inc.

• Medtronic

• F. Hoffmann-La Roche Ltd

• Novo Nordisk A/S

• Ascensia Diabetes Care Holdings AG

• Bionime Corporation

• Agamatrix, Inc.

• Lifescan IP Holdings, LLC

• Insulet Corporation

• Lilly

• Sanofi

• Rossmax International Ltd.